We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
91 hedge funds and large institutions have $85.3M invested in Invesco Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.67% more ownership
Funds ownership: 17.18% → 17.85% (+0.67%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 96 → 91 (-5)
15% less capital invested
Capital invested by funds: $101M → $85.3M (-$15.6M)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
35% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 31
Holders
91
Holders Change
-5
Holders Change %
-5.21%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
20
Reduced
31
Closed
17
Calls
$256K
Puts
–
Net Calls
+$256K
Net Calls Change
-$23K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$4.26M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.76M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.82M |
| 4 |
Jane Street
New York
|
+$1.66M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.58M |
